menu
    • menu

    Company profile for Immutep

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Immutep is a globally active biotechnology company, listed on the Australian Stock Exchange and on the NASDAQ Global Market in the US. As a leader in personalized bio-therapeutic products for cancer, Immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders. Immutep's main pipeline of products is based on the LAG-3 immune ...
    Immutep is a globally active biotechnology company, listed on the Australian Stock Exchange and on the NASDAQ Global Market in the US. As a leader in personalized bio-therapeutic products for cancer, Immutep is dedicated to leveraging its current technology and expertise to develop innovative treatment options for patients and maximize value to shareholders. Immutep's main pipeline of products is based on the LAG-3 immune control mechanism which plays a vital role in the regulation of the T cell immune response. The most clinically advanced product is a T cell immunostimulatory factor (APC activator)

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ImmutepAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 12, 95 Pitt Street Sydney, NSW 2000
    Telephone
    Telephone
    +61 2 9290 9600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.immutep.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/857541/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/immutep?lang=en/

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug
    Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug

    08 Dec 2025

    // PRESS RELEASE

    https://www.drreddys.com/cms/sites/default/files/2025-12/DRLImmuteppressreleasefinalversion.pdf

    PRESS RELEASE
    08 Dec 2025
    Share Share
    EFTISARC-NEO Ph II Data Highlighted In CTOS 2025 Presentation
    EFTISARC-NEO Ph II Data Highlighted In CTOS 2025 Presentation

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187275/0/en/Translational-Data-and-Significant-Pathologic-Response-Rates-from-EFTISARC-NEO-Phase-II-Highlighted-in-Oral-Presentation-at-CTOS-2025.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    French Government Grants Immutep A$4.6M R&D Tax Incentive
    French Government Grants Immutep A$4.6M R&D Tax Incentive

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179212/0/en/Immutep-Receives-A-4-6-million-R-D-Tax-Incentive-from-French-Government.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Immutep Quarterly Activities Report Q1 FY26
    Immutep Quarterly Activities Report Q1 FY26

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176384/0/en/Immutep-Quarterly-Activities-Report-Q1-FY26.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Immutep Showcases Treatment Innovation In First-Line Lung Cancer
    Immutep Showcases Treatment Innovation In First-Line Lung Cancer

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169319/0/en/Two-Posters-at-ESMO-Congress-2025-Highlight-Immutep-s-Focus-on-Changing-Treatment-Landscape-in-First-Line-Non-Small-Cell-Lung-Cancer.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    EFTISARC-NEO Ph2 Meets Endpoint for Efti in Soft Tissue Sarcoma
    EFTISARC-NEO Ph2 Meets Endpoint for Efti in Soft Tissue Sarcoma

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169335/0/en/Primary-Endpoint-Met-in-EFTISARC-NEO-Phase-II-Evaluating-Neoadjuvant-Efti-in-Soft-Tissue-Sarcoma-and-Data-Presented-at-ESMO-Congress-2025.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Contact Immutep and get a quotation

    Immutep is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Eftilagimod Alpha bulk offered by Immutep

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search